Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Apr 19, 2024 10:46am
562 Views
Post# 35998001

Vaccine a plus-$value for Big Pharma...

Vaccine a plus-$value for Big Pharma...This is my last post on TLT-vaccine(or maybe not).

In this link...
https://mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/immunotherapy/cancer-vaccines

Under Therapeutic cancer vaccine.
''Therapeutic cancer vaccine expose your immune system to molecules,called antigens(TLT-vaccine work with antigens),that are associated with specific type of cancer.
These vaccines enable the immune system to recognize and destroy the cancer cells''.

''Therapeutic cancer vaccine can:
1) Stop a tumor from growing or spreading.
2) Destroy cancer cells still in the body after a treatment.
3) Keep cancer from coming back after treatment''.

Why is this a plus-value for a Big Pharma(especially no 2-3)?
Let's say a Big Pharma has a cancer treatment that has a 70%CR rate at 90 days, and the CR% rate drop to 25%CR at 450 days.
If this Big Pharma inject TLT(antigens vaccine) after the initial treatment(around 90 days), because of TLT-vaccine the CR% at 450 days could stabilize around 60-70% after 450 days(instead of 25%CR). 

Now! That is what you call a very big plus-$value for any Big Pharma that will sign a deal with TLT.

I love TLT-vaccine.



<< Previous
Bullboard Posts
Next >>